bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Add to watchlist

2.0200

-0.0500

(-2.42%)

At close: 04:00PM EDT

Loading interactive chart...

Business Wire
bioAffinity Technologies News Update
SAN ANTONIO, May 02, 2024--bioAffinity reports ramp in sales of CyPath® Lung, expanded sales team, new Patient Coach and upcoming presentation at American Thoracic Society.
Business Wire
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
SAN ANTONIO, April 24, 2024--bioAffinity Technologies is developing diagnostics based on its proprietary platform for use with BAL fluid to detect lung cancer and to detect COPD.
Business Wire
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
SAN ANTONIO, April 09, 2024--bioAffinity Technologies and the American Cancer Society are expanding their campaign to raise funds for lung cancer screening.